OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right

Search Results

Your search returned 13 results.
Search:

SKU Category Vector Description Price Delivery
/ CRISPR CLK3 - human gene knockout kit via CRISPR $1200 4 Weeks
SC323161 Human cDNA pCMV6-Entry CLK3 (untagged)-Human CDC-like kinase 3 (CLK3), transcript variant 1 NM_001130028.1 $960 2-3 weeks
RC226050 Human ORF PS100001 CLK3 (Myc-DDK-tagged)-Human CDC-like kinase 3 (CLK3), transcript variant 1 $770 Immediate
RC226050L1 Human ORF PS100064 Lenti ORF clone of Human CDC-like kinase 3 (CLK3), transcript variant 1 , Myc-DDK-tagged $1140 3-4 weeks
RC226050L2 Human ORF PS100071 Lenti ORF clone of Human CDC-like kinase 3 (CLK3), transcript variant 1, mGFP tagged $1250 3-4 weeks
RG226050 Human ORF PS100010 CLK3 (GFP-tagged) - Human CDC-like kinase 3 (CLK3), transcript variant 1 $850 2-3 weeks
TF320306 Human shRNA pRFP-C-RS CLK3 - Human, 4 unique 29mer shRNA constructs in retroviral RFP vector $498 In Stock
TG320306 Human shRNA pGFP-V-RS CLK3 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector $650 2 Weeks
TL320306 Human shRNA pGFP-C-shLenti CLK3 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector $750 2 Weeks
TL320306V Human shRNA pGFP-C-shLenti CLK3 - Human shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^6 TU/ml. $1200 5 weeks
TR320306 Human shRNA pRS CLK3 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector $650 2 Weeks
/ Human siRNA CLK3 (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each $300 In Stock
/ UTR pMirTarget 3`UTR clone of CDC-like kinase 3 (CLK3) transcript variant 1 for miRNA target validation NM_001130028.1 $495 3-4 weeks
Inc 5000 Healthcare Company
All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title